Skip to main content

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Media Contact: Amy Hytowitz, 949-250-5070

Investor Contact: Mark Wilterding, 949-250-6826

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.56
+4.28 (2.09%)
AAPL  272.11
+5.93 (2.23%)
AMD  215.30
+18.70 (9.51%)
BAC  50.41
-0.66 (-1.28%)
GOOG  311.61
-0.08 (-0.03%)
META  640.14
+2.89 (0.45%)
MSFT  386.26
+1.79 (0.47%)
NVDA  193.19
+1.64 (0.86%)
ORCL  144.78
+3.47 (2.46%)
TSLA  404.05
+4.22 (1.06%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.